Nivolumab
Nivolumab anti-PD-1) is a genetically engineered fully human immunoglobulin Ig) G4 monoclonal antibody directed against the negative immunoregulatory human cell surface receptor programmed death-1PD-1PCD-1) with immune checkpoint inhibitory and antineoplastic activities.
Product Specifications
CAS Number
946414-94-4
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
146 kDa
Molecular Formula
——
Notes
Research use only, not for human use.
Receptor
PD-1
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
041754-ML405 100 µL
SIRPB2, CT (SIRPB2, PTPN1L, PTPNS1L3, Signal-regulatory protein beta-2, Protein tyrosine phosphatase non-receptor type substrate 1-like 3, Protein tyrosine phosphatase non-receptor type substrate protein) (MaxLight 405) discontinued
Ask
View Details 
RC229876L2V 200 µL
G protein alpha Inhibitor 2 (GNAI2) (NM_001166425) Human Tagged ORF Clone Lentiviral Particle
Ask
View Details 